Puma Biotechnology director sells shares, gets RSUs
Puma Biotechnology director Troy Edward Wilson reported both a stock grant and a sale of shares of common stock.
Rhea-AI Filing Summary
Puma Biotechnology director Troy Edward Wilson reported both a stock grant and a sale of shares of common stock. He received 27,000 Restricted Stock Units (RSUs) that vest in full on the earlier of one year from grant or the next annual shareholder meeting, subject to his continued service with the company.
Wilson also completed an open-market sale of 10,800 shares at a weighted average price of $7.1989 per share under a pre-arranged Rule 10b5-1(c) trading plan adopted on 03-12-2025. Following these transactions, he holds 59,750 shares directly, plus 550 shares indirectly through accounts for two children.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 10,800 shares
Net Sell
4 txns
Insider
WILSON TROY EDWARD
Role
Director
Sold
10,800 shs ($78K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 10,800 | $7.1989 | $78K |
| Grant/Award | Common Stock | 27,000 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 59,750 shares (Direct);
Common Stock — 400 shares (Indirect, By Child #1);
Common Stock — 150 shares (Indirect, By Child #2)
Footnotes (3)
- F1. Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer.
- F2. Adoption date of referenced 10b5-1(c) plan is: 03-12-2025
- F3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.98 to $7.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Key Figures
Shares sold: 10,800 shares
Sale price (weighted average): $7.1989 per share
Sale price range: $6.98–$7.32 per share
+4 more
7 metrics
Shares sold
10,800 shares
Open-market sale of common stock
Sale price (weighted average)
$7.1989 per share
Weighted average sale price for 10,800 shares
Sale price range
$6.98–$7.32 per share
Price range of multiple sale transactions
RSUs granted
27,000 units
Restricted Stock Units awarded to director
Direct holdings after transactions
59,750 shares
Common stock held directly by Wilson post-transaction
Indirect holdings (children)
550 shares
400 shares for Child #1, 150 shares for Child #2
10b5-1 plan adoption date
03-12-2025
Adoption date of the Rule 10b5-1(c) trading plan
Key Terms
Restricted Stock Units, Rule 10b5-1(c) plan, weighted average price
3 terms
Restricted Stock Units financial
"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant..."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Rule 10b5-1(c) plan regulatory
"Adoption date of referenced 10b5-1(c) plan is: 03-12-2025"
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
FAQ
What insider transactions did PBYI director Troy Edward Wilson report?
Troy Edward Wilson reported a grant and a sale. He received 27,000 Restricted Stock Units and sold 10,800 shares of Puma Biotechnology common stock in an open-market transaction, all detailed in the Form 4 insider trading report.
What RSU award did PBYI grant to director Troy Edward Wilson?
Wilson received 27,000 Restricted Stock Units (RSUs). These RSUs vest in full on the earlier of the one-year anniversary of the grant date or the next annual shareholder meeting, contingent on his continued service with Puma Biotechnology.
When will Troy Edward Wilson’s Puma Biotechnology RSUs vest?
The RSUs vest on the earlier of two dates. They vest in full on the one-year anniversary of the grant date or on the date of the next annual shareholder meeting, assuming his continued service with Puma Biotechnology through that time.
AI-generated analysis. How Rhea-AI works. Not financial advice.
